Live from the NIH registry
Studies recruiting near Fort Collins right now
Top 25 of 162 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 944 participants sought
UCHealth Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: Pfizer
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Advanced Vision Research Institute — Longmont, Colorado (26.4 mi)
· Sponsor: Genentech, Inc.
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
UC Health Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: Edwards Lifesciences
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: SWOG Cancer Research Network
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Advanced Neurosciences Research — Fort Collins, Colorado (2.8 mi)
· Sponsor: Kallyope Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: NRG Oncology
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Advanced Neurosciences Research, LLC /ID# 247592 — Fort Collins, Colorado (2.8 mi)
· Sponsor: AbbVie
Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance
Fat Metabolism
N/A
Interventional 30 participants sought
Colorado State University — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
McKee Medical Center — Loveland, Colorado (10.4 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System — Fort Collins, Colorado (2.8 mi)
· Sponsor: Hoffmann-La Roche
Brain Stimulation Effects on Cognitive Task Performance
Cognitive Function
N/A
Interventional 100 participants sought
Colorado State University Department of Psychology — Fort Collins, Colorado (2.8 mi)
· Sponsor: Colorado State University
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: NRG Oncology
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos
N/A
Interventional 535 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Relapsing Multiple Sclerosis
Phase 3
Interventional 800 participants sought
TG Investigational Site — Fort Collins, Colorado (2.8 mi)
· Sponsor: TG Therapeutics, Inc.
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Fort Collins, Colorado (2.8 mi)
· Sponsor: TG Therapeutics, Inc.
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Advanced Neurology of Colorado — Fort Collins, Colorado (2.8 mi)
· Sponsor: Genentech, Inc.
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 500 participants sought
UCHealth Medical Center of the Rockies — Loveland, Colorado (10.4 mi)
· Sponsor: Orchestra BioMed, Inc
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Rocky Mountain Cancer Centers LLP — Longmont, Colorado (26.4 mi)
· Sponsor: Pfizer
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado (10.4 mi)
· Sponsor: National Cancer Institute (NCI)
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Extensive Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma, A Subtype
Phase 2
Interventional 900 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 94 participants sought
Longmont United Hospital — Longmont, Colorado (26.4 mi)
· Sponsor: SWOG Cancer Research Network
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Poudre Valley Hospital — Fort Collins, Colorado (2.8 mi)
· Sponsor: NRG Oncology